Reuters logo
BRIEF-Allergan announces FDA approval of byvalson
2016年6月6日 / 中午11点37分 / 1 年前

BRIEF-Allergan announces FDA approval of byvalson

June 6 (Reuters) - Allergan Plc :

* Allergan expects byvalson to be available in 2nd half of 2016.

* Approval of byvalson 5 mg/ 80 mg tablets, by U.S. food and drug administration (FDA) for treatment of hypertension to lower blood pressure

* Allergan announces FDA approval of byvalson(tm) (nebivolol and valsartan) Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below